Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation

The NIH, NSF, and FDA jointly initiated the tri-agency digital twins program to support foundational research in biomedical digital twin development. This program will utilize NSF's proposal and award management infrastructure. Its governance will be overseen by the tri-agency FDT-BioTech working group consisting of NIH, NSF and FDA program officials.

Synopsis of the Program

The Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech) program supports inherently interdisciplinary research projects that underpin the mathematical and engineering foundations behind the development and use of digital twins and synthetic data in biomedical and healthcare applications, with a particular focus on digital, in silico models used in the evaluation of medical devices and the relevance of the developed models in addressing current and emerging challenges affecting the development and assessment of biomedical technologies. The goal of the FDT-BioTech initiative is to catalyze biomedical technological innovation through new foundational development of methods and algorithms relevant to digital twins and synthetic humans.

Review full program guidelines

Read the NSF Solicitation NSF 24-561